Anavex Life Sciences Corp. announced the addition and appointment of new senior team members with a track record of successfully bringing drugs to market. Reinforcing the Company?s commitment to drive.
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% and liver triglycerides by 67% compared to placebo two months after administration Data also.
Fractyl Health Presents Compelling Preclinical Data from globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.